100年後の英国における小児性急性リンパ性白血病
1Paediatric Haematology, Bristol Royal Hospital for Children, Bristol, UK.
Archives of disease in childhood
|February 23, 2026
まとめ
過去"世紀,英国の小児急性リンパ性白血病の治療は,著しい進歩を遂げました. 英国の試験は,この状態の子供たちの治療結果を改善する上で重要な役割を果たしてきました.
科学分野:
- 小児腫瘍学 小児腫瘍学
- クリニック・トライアル 臨床試験
- 白血病に関する研究
背景:
- 急性リンパ性白血病 (ALL) は,重要な小児がんです.
- 歴史的に見て,小児ALLのアウトカムが悪かった.
- 治療の進歩は,生存率を劇的に改善しました.
研究 の 目的:
- イギリスにおける小児ALL治療の100年間の発展を振り返る.
- UK ALLの臨床試験の役割を強調する.
- 患者のケアと成果の改善を目立たせること.
主な方法:
- イギリスにおける小児ALL治療の歴史的レビュー.
- イギリスの急性リンパ性白血病試験からの貢献の分析.
- 治療の進化とサポートケアの改善の概要.
主要な成果:
- 100年以上にわたり,小児ALL治療プロトコルにおける実証可能な進歩.
- 治療戦略に対するUK ALL試験の重要な影響.
- 小児患者の生存率と生活の質の顕著な改善.
結論:
- イギリスの臨床試験は,小児ALL治療の進歩に大きく貢献しています.
- 継続的な研究と共同試験は,さらなる進歩のために不可欠です.
- イギリスにおける小児ALL治療の旅は,小児腫瘍学における大きな成功を象徴しています.
関連する概念動画
Probability Laws
Overview
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...


